Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 9, Issue 5, Pages 264-275
Publisher
Elsevier BV
Online
2021-03-31
DOI
10.1016/s2213-8587(21)00046-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
- (2020) Jacqueline S. Dron et al. BMC Medical Genomics
- The polygenic nature of mild-to-moderate hypertriglyceridemia
- (2020) Jacqueline S. Dron et al. Journal of Clinical Lipidology
- Hypertriglyceridemia-induced acute pancreatitis: A prospective, multicenter, international cohort analysis of 716 acute pancreatitis cases
- (2020) Dóra Mosztbacher et al. PANCREATOLOGY
- N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
- (2019) Veronica J Alexander et al. EUROPEAN HEART JOURNAL
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roundtable on etiology of familial chylomicronemia syndrome
- (2018) William Virgil Brown et al. Journal of Clinical Lipidology
- Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
- (2018) Robert A. Hegele et al. Journal of Clinical Lipidology
- Extreme Hypertriglyceridemia: genetic diversity, pancreatitis, pregnancy, and prevalence
- (2018) Vadzim Chyzhyk et al. Journal of Clinical Lipidology
- Severe hypertriglyceridemia is primarily polygenic
- (2018) Jacqueline S. Dron et al. Journal of Clinical Lipidology
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist
- (2016) Daniel Gaudet et al. Journal of Clinical Lipidology
- Severe hypertriglyceridemia and factors associated with acute pancreatitis in an integrated health care system
- (2016) Nazia Rashid et al. Journal of Clinical Lipidology
- Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis
- (2016) Simon B. Pedersen et al. JAMA Internal Medicine
- Elevated Serum Triglycerides are Independently Associated With Persistent Organ Failure in Acute Pancreatitis
- (2015) Haq Nawaz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
- (2015) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia
- (2013) Jennifer B. Christian et al. AMERICAN JOURNAL OF MEDICINE
- Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
- (2013) Lars Berglund et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
- (2013) Björn Lindkvist et al. PANCREATOLOGY
- Acute Pancreatitis in a Cohort of 129 Patients Referred for Severe Hypertriglyceridemia
- (2009) Célia Lloret Linares et al. PANCREAS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started